
GL-ENH-STRIP
The GlucoLeader Enhance Blood Glucose Strip incorporates an advanced electrochemical biosensor platform combined with a highly stable GDH-FAD (Glucose Dehydrogenase-FAD) enzyme matrix, specifically engineered for precision capillary and venous whole blood analysis. Uniquely designed with an innovative "Dual-Side Aperture" mechanism, it gives users ultimate flexibility by allowing blood application from either the left or right side. Paired with our factory-preset code technology, it proactively shields test results against interference from non-glucose sugars, standing as a trusted, high-performance core consumable.
Ergonomic Dual-Side Application
Engineered with breakthrough left-and-right side openings for versatile blood sampling, adapting to any testing angle or user preference.
Extended Length for Effortless Handling
An elongated strip design and increased surface area make it exceptionally easy to grip and insert, even for elderly users.
Elite GDH-FAD Enzyme Accuracy
Advanced Glucose Dehydrogenase technology targets D-glucose exclusively, eliminating interferences from galactose, maltose, or oxygen fluctuations.
High-Conductivity Precision Electrodes
Ultra-stable electrode circuitry provides superb electron transfer rates, securing robust lot-to-lot consistency and reproducibility.
Broad 10% - 70% Hematocrit Tolerance
Delivers consistent diagnostic fidelity across a sweeping 10% to 70% Hematocrit (HCT) spectrum under diverse blood profiles.
| Assay Method | Amperometry glucose biosensor |
|---|---|
| Blood Test Volume | 0.8 μL |
| Reaction Time | 5 Seconds |
| Measuring Range | 10 - 600 mg/dL (0.56 - 33.3 mmol/L) |
| Blood Sample Type | Capillary and Venous whole blood |
| Hematocrit (HCT) Range | 10% - 70% |
| Calibration | Factory Set One Code |
| Storage Conditions | Original vial packaging, 2°C to 30°C |
| Origin | Made In Taiwan |
| TFDA License No. | 衛部醫器製字第005184號 |